Similar articles

• [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].

  Krawietz W, Weinsteiger M, Pruchniewski M, Erdmann E. Krawietz W, et al. Verh Dtsch Ges Kreislaufforsch. 1977;43:414-5. Verh Dtsch Ges Kreislaufforsch. 1977. PMID: 26149 German. No abstract available.
• Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.

  William-Olsson T, Fellenius E, Björntorp P, Smith U. William-Olsson T, et al. Acta Med Scand. 1979;205(3):201-6. doi: 10.1111/j.0954-6820.1979.tb06031.x. Acta Med Scand. 1979. PMID: 218427 Clinical Trial.
• [Terbutaline-induced metabolic responses after propranolol and metoprolol].

  Chowanetz W, Schramm A. Chowanetz W, et al. Wien Klin Wochenschr. 1982 Dec 24;94(24):658-62. Wien Klin Wochenschr. 1982. PMID: 6303001 Clinical Trial. German.
• Comparative review of beta-blocking agents.

  Jackson EA, Sullman SA. Jackson EA, et al. Conn Med. 1984 Apr;48(4):213-5. Conn Med. 1984. PMID: 6143648 Review. No abstract available.
• beta-Adrenoceptor antagonists: new drugs and new indications.

  Koch-Weser J, Frishman WH. Koch-Weser J, et al. N Engl J Med. 1981 Aug 27;305(9):500-6. doi: 10.1056/NEJM198108273050907. N Engl J Med. 1981. PMID: 6114433 Review. No abstract available.